BridgeBio Pharma Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2019 | $-59.1M | $-59.6M | $427.0K | $2.2M |
| Mar 2020 | $-83.9M | $-88.4M | $4.5M | $10.2M |
| Mar 2021 | $-150.8M | $-152.7M | $2.0M | $33.6M |
| Mar 2022 | $-160.6M | $-161.5M | $859.0K | $24.1M |
| Mar 2023 | $-144.3M | $-144.3M | $12.0K | $21.9M |
| Mar 2024 | $-219.5M | $-220.2M | $695.0K | $17.1M |
| Mar 2025 | $-199.2M | $-199.2M | $0 | $25.9M |
| Mar 2026 | $-197.3M | $-197.3M | $69.0K | $33.2M |